Post-Hoc: The embryo editing debate is back
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
In genetic medicine, a drumbeat of layoffs and pipeline cuts has replaced the excitement of just a few years ago, when fresh financing rounds were
“A lot of this stuff that happens is because there’s no cops on the beat.” — Vikas Saini, MD, president of the Lown Institute, discussing
Madad is a chief biopreparedness officer. Kindrachuk is an associate professor in medical microbiology and infectious diseases, and a research chair in the molecular pathogenesis
Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients with hidradenitis suppurativa, post hoc analysis of the PIONEER
Amol Dalvi, VP of Product at Nerdio Healthcare is navigating an era of unprecedented technological evolution while contending with rising cybersecurity threats and increasing demands
Philipp Pointner, Chief of Digital Identity at Jumio Healthcare organizations face an increasingly sophisticated array of threats, including AI-generated attacks like deepfakes. These attacks target critical healthcare data, putting patient safety and